
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Alnylam develops RNA interference medicines designed to reduce the production of proteins involved in disease.
Company website ↗Upcoming catalysts
Next 30 days- Dec 12-15, 2026ALN-6400 (PLG)Company source ↗
Phase 1 data